Scott Alan Samuels bought $24k of GERN
EVP, Chief Legal Officer at GERON CORP. 15,000 shares at an average of $1.61, traded Feb 27, 2025, filed Mar 3, 2025.
Score components
- +15RoleOfficer
- 0Trade size$24k at market
- +10Relative to holdingsHoldings up 128%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-030330, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2025 | POpen-market purchase Common Stock | +15,000 | $1.61 | $24k | 26,682 | Mar 3, 2025 |
Related signals
Other insiders at GERON CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | GERNbuy GERON CORP | Bryan Lawlis V director | $16k 13,300 shares | - | |
| 49Moderate | GERON CORP | James Ziegler EVP, Chief Commercial Officer | $160k 100,000 shares | - | |
| 48Moderate | GERON CORP | John A Scarlett Chairman, President and CEO | $22k 12,500 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.